ADL
WVE icon

Asset Dedication LLC’s Wave Life Sciences WVE Stock Holding History

Asset Dedication LLC’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200
Closed -$1K – 1046
2021
Q3 		$1K Hold
200
– – ﹤0.01% 987
2021
Q2 		$1K Buy
+200
New +$1.31K ﹤0.01% 837

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Asset Dedication LLC's WVE Position: Q4 2021 in Review

Asset Dedication LLC sold out of Wave Life Sciences (WVE) in Q4 2021, closing a stake of 200 shares — an estimated $1K sold.

Asset Dedication LLC first reported a position in WVE in Q2 2021 and held it in 2 quarters. The position peaked at $1K in Q3 2021. 90 funds tracked by Wall St. Rank hold WVE as of Q4 2021.

  • Asset Dedication LLC reported no remaining Wave Life Sciences position as of Q4 2021 after selling out during the quarter.
  • Asset Dedication LLC sold 200 Wave Life Sciences shares in Q4 2021, an estimated $1K.
  • Asset Dedication LLC first reported a position in Wave Life Sciences in Q2 2021 and held it in 2 quarters.
  • Asset Dedication LLC's Wave Life Sciences position peaked at $1K in Q3 2021.
  • 90 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2021.

Based on Asset Dedication LLC's 13F filing for Q4 2021, filed 21 Jan 2022.